- Home
- VNDA vs TSI Comparison
VNDA vs TSI Comparison
Compare VNDA & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- TSI
- Stock Information
- Founded
- VNDA 2002
- TSI 1987
- Country
- VNDA United States
- TSI United States
- Employees
- VNDA N/A
- TSI N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- TSI Investment Managers
- Sector
- VNDA Health Care
- TSI Finance
- Exchange
- VNDA Nasdaq
- TSI Nasdaq
- Market Cap
- VNDA 237.9M
- TSI 231.3M
- IPO Year
- VNDA 2006
- TSI N/A
- Fundamental
- Price
- VNDA $3.95
- TSI $4.91
- Analyst Decision
- VNDA Strong Buy
- TSI
- Analyst Count
- VNDA 2
- TSI 0
- Target Price
- VNDA $16.50
- TSI N/A
- AVG Volume (30 Days)
- VNDA 471.1K
- TSI 106.8K
- Earning Date
- VNDA 05-07-2025
- TSI 01-01-0001
- Dividend Yield
- VNDA N/A
- TSI 7.46%
- EPS Growth
- VNDA N/A
- TSI N/A
- EPS
- VNDA N/A
- TSI N/A
- Revenue
- VNDA $201,351,000.00
- TSI N/A
- Revenue This Year
- VNDA $14.36
- TSI N/A
- Revenue Next Year
- VNDA $44.53
- TSI N/A
- P/E Ratio
- VNDA N/A
- TSI N/A
- Revenue Growth
- VNDA 13.37
- TSI N/A
- 52 Week Low
- VNDA $3.85
- TSI $4.48
- 52 Week High
- VNDA $6.75
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- VNDA 33.16
- TSI 57.57
- Support Level
- VNDA $4.20
- TSI $4.85
- Resistance Level
- VNDA $4.51
- TSI $4.93
- Average True Range (ATR)
- VNDA 0.18
- TSI 0.04
- MACD
- VNDA -0.02
- TSI 0.01
- Stochastic Oscillator
- VNDA 1.43
- TSI 84.62
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.